StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
BUDI.JK$204.00-2.86%
Fair $204.00+0.0%

BUDI.JK

PT Budi Starch & Sweetener Tbk

Consumer Defensive / Packaged FoodsJakarta

$204.00

-6.00 (-2.86%)

Fairly Valued+0.0%Fair Value $204.00Fund rank 20/100 · Data gapFallback financials|
SA 29/D
F-Score: 3/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 14%

FCF escenarios

weak_data · normalized FCF $-261.7B · quality 27.0/100

Data gap 20/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 7/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

29/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · BUDI.JKLocal privado en este navegador · PT Budi Starch & Sweetener Tbk
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$916.2B

P/E

7.5x

↓

EV/EBITDA

8.6x

↓

ROE

6.9%

↑

Gross Margin

13.9%

↓

Debt/Equity

1.29

↑
52-Week Range$204
$200$268

TradingView lightweight chart

BUDI.JK price, volumen y niveles de valoración

Último $204.00Periodo +65.8%
Fair value: $204.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-2.1%

FCF CAGR

—

FCF margin

-8.2%

FCF / Net income

-2.46x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $3.18T · net income $106.55B · FCF $-261.67B

2022-FY → 2025-FY

Gross margin

13.9%+1.7% pts

Operating margin

6.9%+0.3% pts

Net margin

3.4%+0.7% pts

FCF margin

-8.2%-5.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$3177.73B$3177.73B$4009.26B$3944.95B$3382.33B
Net Income$106.55B$106.55B$61.62B$100.80B$88.96B
EBITDA$325.35B$325.35B$261.51B$290.62B$262.72B
EPS——13.7022.4119.77
Gross Margin13.9%13.9%10.5%12.2%12.2%
Operating Margin6.9%6.9%5.4%6.2%6.6%
Net Margin3.4%3.4%1.5%2.6%2.6%
Balance Sheet
Debt/Equity1.291.291.140.890.94
Current Ratio1.751.75———
Cash Flow
Free Cash Flow$-261.67B$-261.67B$-377.01B$91.76B$-78.57B
Returns
ROE6.9%6.9%4.1%6.9%6.7%
Valuation
P/E7.507.5016.2011.9611.23
EV/EBITDA8.568.5610.028.248.32
P/B0.590.590.670.820.75
Growth & Yield
Revenue Growth-20.7%-20.7%1.6%16.6%—
EPS Growth——-38.9%13.4%—
Dividend Yield4.4%4.4%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +4.4%

Total return

+4.4%

Start / end P/E

n/dx → n/dx

EPS bridge

13.70 → n/d

Residual

-0.0%

EPS growthn/d
Multiple reratingn/d
Dividend+4.4%
Residual / FX / buybacks / cross-term-0.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.